Achieving complete and precise genome duplication requires that each genomic 2 segment be replicated only once per cell division cycle. Protecting large eukaryotic 3 genomes from re-replication requires an overlapping set of molecular mechanisms that 4 prevent the first DNA replication step, the DNA loading of MCM helicase complexes to 5 license replication origins. Previous reports have defined many such origin licensing 6 inhibition mechanisms, but the temporal relationships among them are not clear, 7 particularly with respect to preventing re-replication in G2 and M phases. Using a 8 combination of mutagenesis, biochemistry, and single cell analyses in human cells, we 9 define a new mechanism that prevents re-replication through hyperphosphorylation of 10 the essential MCM loading protein, Cdt1. We demonstrate that Cyclin A/CDK1 11 hyperphosphorylates Cdt1 to inhibit MCM re-loading in G2 phase. The mechanism of 12 inhibition is to block Cdt1 binding to MCM independently of other known Cdt1 13 inactivation mechanisms such as Cdt1 degradation during S phase or Geminin binding.
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quantitative and consistent measure of Cdt1 phosphorylation, we analyzed Cdt1 191 migration in the presence of Phos-tag reagent which retards protein mobility proportional 192 to the extent of phosphorylation [44] . HA-Cdt1 from nocodazole-arrested cells is a 193 mixture of slow-migrating species on Phos-tag gels compared to HA-Cdt1 from G1 cells, 194 and this migration was accelerated by phosphatase treatment of the lysates in vitro prior 195 to electrophoresis ( Supplementary Fig. S4A ). The distribution of ectopic Cdt1-5A bands whereas Cdt1-S491A migration was indistinguishable from Cdt1-WT (Fig. 3B , lanes 2-5 202 and 8). Cdt1-9A from synchronized cells migrated even faster than Cdt1-7A on Phos-tag 203 gels, demonstrating that one or both T29 and S31 are also phosphorylated after S 204 phase. Moreover, the difference in migration between Cdt1-9A and Cdt1-Cy suggests 205 that either some residual kinase binding remains in the Cy motif mutant or that non-Cy-206 dependent kinases can phosphorylate some of the sites mutated in Cdt1-9A. These 207 patterns indicate that Cdt1 is multiply phosphorylated late in the cell cycle on a collection 208 of sites that includes both the N-terminal CDK sites and importantly, the set of linker 209 phosphorylation sites that inhibit Cdt1 activity and restrict re-replication.
210
Cyclin A/CDK1 is the primary Cdt1 kinase during G2 and M phases.
211
To determine which kinase(s) is responsible for Cdt1 phosphorylation, we assessed 212 the effects of kinase inhibitors. As a first step, we analyzed the migration of endogenous 213 Cdt1 on Phos-tag gels using lysates from asynchronously proliferating or synchronized 214 cells. Cdt1 from asynchronous cells migrates primarily as two bands on Phos-tag gels, 215 and both forms are absent from lysates of UV-irradiated cells. Cdt1 is degraded during 216 repair of UV-induced damage [45] [46] [47] [48] , so we conclude that both bands are endogenous 217 Cdt1. Endogenous Cdt1 in nocodazole-synchronized cells migrated as a tight set of very 218 slow-migrating species that are converted to the two faster forms by phosphatases in 219 vitro prior to gel electrophoresis ( Supplementary Fig S4A, lanes 3 and 4) .
220
We then synchronized cells in nocodazole to induce maximal Cdt1 phosphorylation 221 and tested the effects of pharmacological kinase inhibitors on the migration of 222 endogenous Cdt1 using Phos-tag gels. All nine of the sites we had altered are predicted 223 to be potential targets of both CDKs and MAPKs since all nine are serine or threonine 224 followed by proline [49] [50] [51] [52] (Supplementary Fig. S1 ). Both kinase classes are active in G2 225 [53] [54] [55] , so we postulated that during normal G2 and M phases these Cdt1 sites are 226 phosphorylated by CDK and/or MAPK. In addition to the kinase inhibitors, we also co-227 treated with the proteasome inhibitor MG132 to prevent cyclin or other ubiquitin-228 mediated protein degradation. We first treated nocodazole-arrested cells with inhibitors 229 of p38 or JNK, two stress-activated MAP kinases which we previously showed can 230 phosphorylate the linker region during a stress response [17] 
260
lanes 1 and 2). However, this assay does not distinguish between phosphorylation at the 261 previously studied N-terminal CDK target sites, T29 and S31, and sites in the linker 262 region or elsewhere. To test specifically for linker region phosphorylations, we repeated the in vitro kinase reactions in the presence of unlabeled ATP and then subjected the that antibody production detect Cdt1 phosphorylation by immunoprecipitation followed by 268 immunoblotting with a general Cdt1 antibody; these sera are labelled Ab3 and Ab4. By 269 this method, we detected direct Cyclin A/CDK1-mediated Cdt1 phosphorylation at the 270 inhibitory linker sites in vitro (Fig. 4C, lanes 4 and 6) .
271
Cdt1 phosphorylation blocks MCM binding.
272
We next explored the molecular mechanism of Cyclin A/CDK1-mediated Cdt1 
289
We then set out to test if MCM interacts with hyperphosphorylated G2 Cdt1 less well 290 than with hypophosphorylated G1 Cdt1 (i.e. if phosphorylation impairs Cdt1-MCM 291 binding). We noted however that simply comparing co-immunoprecipitations from lysates 292 of G1 and G2 phase cells is complicated by the presence of the Cdt1 inhibitor, Geminin, 293 which interferes with the Cdt1-MCM interaction and is only present in S and G2 cells.
294
Because Geminin is differentially expressed in G1 and G2 cells, the comparison would 295 not be fair. To account for the effects of Geminin, we prepared a lysate of 296 asynchronously-proliferating, mostly G1 cells, then mixed this lysate with lysate from arrested cells with only hyperphosphorylated Cdt1. As expected, Geminin did not co-303 precipitate with MCM since the Cdt1-Geminin and Cdt1-MCM interactions are mutually 304 exclusive ( Fig. 5C ). Importantly, we found that Cdt1 bound by the MCM complex in the 305 mixed lysates was enriched for the faster migrating hypophosphorylated Cdt1 relative to 306 hyperphosphorylated Cdt1. Moreover, the total amount of Cdt1 bound to MCM was 307 much higher when hypophosphorylated Cdt1 was available than when the only form of 308 Cdt1 was hyperphosphorylated (Fig. 5C , compare lanes 5 and 6). This preferential 309 binding suggests that Cdt1 phosphorylation disrupts interaction with the MCM complex, 310 and that this disruption contributes to re-replication inhibition in G2 and M phases. We 311 note that this is the first example of direct regulation of the Cdt1-MCM interaction by 312 post-translational modification.
313
Cdt1 dephosphorylation at the M-G1 transition requires PP1 phosphatase activity.
314
Our finding that Cdt1 phosphorylation in G2 and M phase inhibits its ability to bind 315 MCM suggests that Cdt1 must be dephosphorylated in the subsequent G1 phase to 316 restore its normal function. To explore this notion, we first monitored Cdt1 expression 317 and phosphorylation in cells progressing from M phase into G1. We released 318 nocodazole-arrested cells and collected time points for analysis by immunoblotting ( Fig. 
319
6A). Like the mitotic cyclins, Geminin is a substrate of the Anaphase Promoting 320 Complex/Cyclosome (APC/C) [59] , and as expected for an APC/C substrate, Geminin 321 was degraded within 60 minutes of mitotic release. In contrast, Cdt1 was not degraded 322 during the M-G1 transition but rather, was rapidly dephosphorylated coincident with 323 Geminin degradation (Fig. 6A, compare lanes 3 and 4) . We next investigated which 324 phosphatase is required for Cdt1 dephosphorylation. We first tested phosphatase 325 inhibitors for the ability to prevent Cdt1 dephosphorylation after CDK1 inhibition. We 326 tested inhibitors of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), 327 and these two families account for the majority of protein dephosphorylation in cells [60] . is more effective than okadaic acid for inhibiting PP1, particularly at the concentrations 332 we tested [62] . We found that calyculin A preserved Cdt1 hyperphosphorylation ( Fig. 6B , 333 compare lanes 2 and 3) whereas low concentrations of okadaic acid that inhibit PP2A 334 but not PP1 did not affect Cdt1 dephosphorylation ( Supplementary Fig. S5 ). In addition,
335
we released nocodazole-arrested cells into G1 phase for 30 minutes (to initiate mitotic 336 progression) and then treated the cells with calyculin A. As a control, we probed for 337 MCM4, a known PP1 substrate that is normally dephosphorylated in G1 phase [63]; 338 calyculin A prevented MCM4 dephosphorylation ( Fig. 6C ). PP1 inhibition also largely 339 prevented Cdt1 dephosphorylation during the mitosis-G1 phase transition without 340 blocking overall mitotic progression as evidenced by Geminin degradation (Fig. 6C , 341 lanes 2 and 3). These results suggest that a PP1 family phosphatase is required for 342 Cdt1 dephosphorylation. By extension, we suggest that PP1 activity is required to re-343 activate Cdt1-MCM binding and origin licensing in G1 phase.
344

Discussion
345
Cell cycle-dependent Cdt1 phosphorylation 346 Metazoan Cdt1 is degraded during S phase, and this degradation is essential to 347 prevent re-replication [34, 40, 64, 65] . Perhaps counter-intuitively, Cdt1 then actively 348 accumulates beginning in late S phase, and by mitosis reaches a level similar to Cdt1 in 349 G1 phase [16] [17] [18] [19] [20] [21] . Despite the potential risk for re-licensing and re-replicating G2 DNA, 350 these high Cdt1 levels serve two purposes: 1) Cdt1 is essential for stable kinetochore-351 microtubule attachments [21, 66] , and 2) high levels of Cdt1 in mitosis can improve 352 licensing efficiency in the next G1 phase [18] . In this study, we discovered that Cdt1 353 phosphorylation during G2 phase inhibits Cdt1 licensing activity and contributes to 354 preventing DNA re-replication during the time that Cdt1 levels are high in G2 and M 355 phase.
356
We analyzed a cluster of Cyclin A/CDK1-dependent phosphorylation sites that are 357 distinct from the previously characterized CDK sites at T29 and S31. This region of Cdt1
358
is not strongly conserved among vertebrates ( Fig. 1A and Supplementary Fig. S1 ), but 359 most vertebrate Cdt1 linker sequences are nonetheless predicted to be similarly 360 disordered, and most have at least one candidate CDK phosphorylation site 361 ( Supplementary Fig. S1 ). Interestingly, altering two additional sites in this region did not 362 exacerbate the re-replication phenotype suggesting that four phosphorylations are Cyclin A/CDK1, its activity is clearly also lost after treatment with a relatively selective 379 CDK1 inhibitor. We also acknowledge that in actively proliferating cells Cyclin A/CDK2 380 could contribute to direct Cdt1 inactivation in late S and G2 phase in a time window after 381 Cdt1 accumulation but before substantial Cyclin A/CDK1 activation, but our 382 synchronization experiment did not detect a role for CDK2 activity.
383
We demonstrate here that the CDK docking motif at Cdt1 positions 68-70 is required 384 for phosphorylation not only at the previously investigated T29 position, but also at sites 385 more than 300 residues towards the Cdt1 C-terminus. The structure of the yeast Cdt1- 
408
We had previously established that the p38 and JNK stress-activated MAP kinases 409 can phosphorylate at least some of these same inhibitory sites in Cdt1 [17] , and a 410 separate study reported a subset of these plus additional sites as potential JNK targets 411 [41] . Both p38 and JNK are active during a G2 arrest [53-55, 73, 74] , but our inhibitor 412 results indicate that Cyclin A/CDK1 is dominant for Cdt1 phosphorylation during G2 and 413 M phases in these cells. On the other hand, our findings here also shed light on the 414 molecular mechanism of stress-induced origin licensing inhibition [17] . We postulate that 415 stress MAPK-mediated Cdt1 hyperphosphorylation at the linker region blocks Cdt1-MCM 416 binding in stressed G1 cells to prevent origin licensing. This phosphorylation blocks 417 initial origin licensing by the same mechanism that prevents origin re-licensing in G2 and 418 M phases. The p38 MAPK family is also active in quiescent cells [53, 54] , and Cdt1 from 419 lysates of serum-starved cells has slower gel mobility reminiscent of the same shift we 420 and other observe in G2 and M phase cells [17] . We thus speculate that Cdt1 in 421 quiescent cells is inhibited by a similar mechanism as the one we defined here.
422
The nine phosphorylation sites we tested in this study are certainly not the only 
435
Approximately one-third of all eukaryotic proteins may be dephosphorylated by PP1
436
[60]. PP1 binds some of its substrates directly via a short motif, RVxF, KGILK or RKLHY 437 [60, 76] . Human Cdt1 contains several such candidate PP1 binding motifs and thus may 438 be a direct target of PP1. Alternatively, Cdt1 dephosphorylation may require an adapter
Geminin prevents re-licensing [35, 36] . This inhibition is particularly important once Cdt1 465 re-accumulates after S phase is complete [37] . Just as CRL4 Cdt2 -mediated degradation 466 in S phase is not sufficient to fully prevent re-replication, we demonstrated that the 467 presence of Geminin alone is not sufficient to inhibit Cdt1 during G2. Cdt1 468 phosphorylation in a linker domain between two MCM binding sites also prevents Cdt1-469 MCM binding. These (and potentially more) mechanisms to restrain Cdt1 activity are 470 also reinforced by regulation to inhibit ORC, Cdc6, PR-Set7, and other licensing 471 activators [4, 33, 80, 81] . The relative importance of any one mechanism will be 472 influenced by cell type and species. Given that there are many thousands of origins in 473 mammalian genomes, and the consequences of even a small amount of re-replication 474 are potentially dire, we suggest that precise once-and-only-once replication requires that 514 micrococcal nuclease (Roche). Lysates were sonicated for 10 seconds at low power 515 followed by incubation on ice for 30 minutes and clarification by centrifugation at 13,000 516 x g for 15 minutes at 4°C. The supernatants were incubated with nickel NTA agarose 517 beads (Qiagen) for 2 hours at 4°C with rotation. Beads were rinsed 4 times rapidly with 518 ice-cold lysis buffer followed by boiling in SDS sample buffer for 5 minutes prior to 519 immunoblot.
520
For co-immunoprecipitation assays, cells were lysed in Co-IP buffer (50 mM HEPES pH 521 7.2, 33 mM KAc, 1 mM MgCl2, 0.5% triton X-100, and 10% glycerol) containing protease 522 inhibitors (0.1 mM AEBSF, 10 µg/mL pepstatin A, 10 µg/mL leupeptin, 10 µg/mL micrococcal nuclease (Roche). Lysates were sonicated for 10 seconds at low power followed by incubation on ice for 30 minutes and clarification by centrifugation at 13,000 527 x g for 15 minutes at 4°C. The supernatants were incubated and rotated with Protein A 528 beads (Roche) with an anti-Mcm2 antibody (Bethyl, 1:1000) at 4°C with rotation for 4 529 hours. Beads were rinsed three times with ice-cold co-IP buffer then eluted by boiling in 530 sample buffer for subsequent immunoblot analysis.
531
Immunofluorescence microscopy 532 U2OS cells cultured on cover glass were fixed with 4% PFA for 15 minutes and 533 permeabilized with 0.5% Triton in PBS for 5 minutes. Cells were blocked in 1% BSA for 
540
For cell cycle analysis, cells were cultured in complete medium with 1 ug/ml doxycycline 541 for 48 hours. Cells were pulse labeled with 10 µM EdU (Sigma) for 60 minutes prior to 542 harvesting by trypsinization. Cells were washed with PBS and then fixed in 4% 543 paraformaldehyde (Sigma) followed by processing for EdU conjugation to Alexa Fluor 544 647-azide (Life Technologies). Samples were centrifuged and incubated in PBS with 1 545 mM CuSO 4 , 1 mM fluorophore-azide, and 100 mM ascorbic acid (fresh) for 30 min at 546 room temperature in the dark then washed with PBS. Total DNA was detected by 547 incubation in 1 µg/mL DAPI (Life Technologies) and 100 µg/mL RNAse A (Sigma).
548
For MCM loading analysis, U2OS cells were cultured in complete medium with 0.05 549 μg/mL doxycycline for 24 hours to induce expression of ectopic constructs..
550
Approximately 20% of this suspension was reserved for subsequent immunoblotting 551 analysis while the remaining 80% was analyzed for bound MCM as described in Matson 552 et al. [42] . Briefly, cells were extracted in cold CSK buffer (10 mM Pipes pH 7.0, 300 mM 553 sucrose, 100 mM NaCl, 3 mM MgCl2) supplemented with 0.5% triton X-100, protease 554 inhibitors (0.1 mM AEBSF, 1 µg/mL pepstatin A, 1 µg/mL leupeptin, 1 µg/mL aprotinin), 
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Quantification of the experiments in (Fig. 1B and 1C) showing all cell cycle phase 767 distributions (G1, S, G2/M, and re-replication). n >4. . Endogenous Cdt1 phosphorylation was analyzed by standard or Phos-tag SDS-PAGE followed by immunoblotting; total protein stain serves as a loading control. The results are representative of three independent experiments. C) Nocodazole-arrested U2OS cells (lane 2) were released into fresh medium for 3 hours and mock treated (lane 1) or treated with 20 nM calyculin A 30 minutes after release (lane 3). Endogenous Cdt1 or MCM4 phosphorylation and total Geminin were detected by immunoblotting; total protein stain serves as a loading control. The results are representative of three independent experiments. D) Model. In S phase Cdt1 is targeted for degradation, first by the CRL4 Cdt2 E3 ubiquitin ligase at the onset of S phase and then additionally by SCF Skp2 after phosphorylation by Cyclin A/CDK2. Geminin accumulates starting in early S phase. The amount of duplicated DNA at risk of re-replication is lowest in early S and highest in G2. In late S and G2 phase Cdt1 re-accumulates and Geminin is at high levels. Cyclin A/CDK1 phosphorylates Cdt1, and both Geminin and Cdt1 hyperphosphorylation independently block Cdt1-MCM binding. At the M→G1 transition Protein Phosphatase 1 is required for Cdt1 dephosphorylation to reactivate MCM loading by Cdt1, ORC, and Cdc6.
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